United States · Venture startup

Who invested in Arcascope

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2025, from 1 source

Latest round
VentureFeb 2025
Investors
2
See who backed them

The rounds

  1. Feb 2025
    VentureAmount undisclosed

    Source recorded

Founders and team

From the SEC filings it signed: 2 on the team.

  • Daniel ForgerExecutive Officer, Directori
  • Olivia WalchExecutive Officer, Directori

On the board, as filediMichael Masterson

Everyone who backed them

MassChallengeAccelerator1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Arcascope as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

New Dominion AngelsAngel networkPer its own site
Supermoon CapitalVC firmPer its own site
Accelerate Blue FundVC firmPer its own site
AioT Health Venture Capital FundVC firmPer its own site

Quick answers about Arcascope

Who invested in Arcascope?

Arcascope's investors include MassChallenge and National Institutes of Health.

How much has Arcascope raised?

Arcascope has raised 1 round since 2025, none with a disclosed amount.

When did Arcascope last raise?

Arcascope's most recent round was a Venture in Feb 2025.

Who backed Arcascope first?

Arcascope's first round on record, in Feb 2025, was backed by MassChallenge and National Institutes of Health.

What stage is Arcascope at?

Arcascope's latest named round is a Venture, in Feb 2025.

Where is Arcascope based?

Arcascope is based in the United States.

Companies like Arcascope

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.